Overall, out of 304 participants, 282 (92.8%) concluded the trial by attending the end-of-trial safety evaluation, 272 (89.5%) underwent body weight assessment at the week 104 end-of-treatment visit to determine the long term effects of semaglutide, and 243 (79.9%) adhered to the treatment protocol until the end-of-treatment visit (Fig
Treatment is monitored with regular lab work, and protocols are adjusted based on your response
Effects of combination therapy with metformin and liraglutide on vascular endothelial function in ApoE / mice To verify vascular protective effects of the combination therapy in vivo , we used high fat diet (HFD)-fed ApoE / mice as our model
doi: 10.1016/j.celrep.2024.114633 350
Pregnant woman Patient with cardiovascular problem * The result depends on individual metabolism
Weight Loss : For those using semaglutide for weight management, significant results typically appear after 4-12 weeks of consistent use